PLGLB1 | OmnibusX

Name	Number of supported studies	Average coverage
hepatocyte	4 studies	65% ± 20%	Explore

sc-RNAseq data

Insufficient scRNA-seq data for expression of PLGLB1 at tissue level.

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
liver	100%	378.85	226 / 226	47%	0.98	190 / 406
brain	98%	131.44	2581 / 2642	2%	0.03	14 / 705
spleen	98%	72.18	236 / 241	0%	0	0 / 0
thymus	95%	49.37	622 / 653	3%	0.04	16 / 605
ovary	93%	42.56	167 / 180	0%	0.01	2 / 430
prostate	93%	53.56	227 / 245	0%	0.00	1 / 502
uterus	91%	49.44	155 / 170	0%	0.01	2 / 459
intestine	90%	36.97	873 / 966	0%	0.00	1 / 527
bladder	90%	33.67	19 / 21	0%	0	0 / 504
breast	88%	30.98	404 / 459	1%	0.01	6 / 1118
esophagus	88%	31.21	1276 / 1445	0%	0	0 / 183
kidney	85%	36.70	76 / 89	0%	0.00	1 / 901
stomach	81%	23.46	290 / 359	0%	0	0 / 286
skin	80%	29.27	1449 / 1809	0%	0	0 / 472
adipose	80%	26.88	960 / 1204	0%	0	0 / 0
blood vessel	76%	19.35	1012 / 1335	0%	0	0 / 0
muscle	76%	20.10	608 / 803	0%	0	0 / 0
adrenal gland	73%	19.57	188 / 258	0%	0	0 / 230
lung	71%	23.22	409 / 578	0%	0	0 / 1155
heart	70%	18.35	604 / 861	0%	0	0 / 0
pancreas	70%	15.80	228 / 328	0%	0	0 / 178
peripheral blood	63%	17.93	582 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
eye	0%	0	0 / 0	0%	0	0 / 80
gingiva	0%	0	0 / 0	0%	0	0 / 0
lymph node	0%	0	0 / 0	0%	0	0 / 29
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
tonsil	0%	0	0 / 0	0%	0	0 / 45
ureter	0%	0	0 / 0	0%	0	0 / 1

Gene name	PLGLB1
Protein name	Plasminogen-like protein B (Plasminogen-related protein B) Plasminogen like B1
Synonyms	PRGB; PLGP1 PLGL PLGLB2
Description	FUNCTION: May bind noncovalently to lysine binding sites present in the kringle structures of plasminogen. This may interfere with the binding of fibrin or alpha-2-antiplasmin to plasminogen and may result in the localization of activity at sites necessary for extracellular matrix destruction.
Accessions	ENST00000355705.4 ENST00000409795.5 F8WCD6 ENST00000409310.6 ENST00000359481.9 ENST00000410086.3 Q02325 ENST00000409801.5

PLGLB1 report